Skip to main content

Peer Review reports

From: Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients

Original Submission
29 Jul 2020 Submitted Original manuscript
2 Sep 2020 Reviewed Reviewer Report - Belaynew Wasie Taye
9 Sep 2020 Reviewed Reviewer Report
21 Sep 2020 Author responded Author comments - Wenjun Wang
Resubmission - Version 2
21 Sep 2020 Submitted Manuscript version 2
27 Sep 2020 Reviewed Reviewer Report - Belaynew Wasie Taye
5 Oct 2020 Reviewed Reviewer Report
9 Nov 2020 Reviewed Reviewer Report
15 Jan 2021 Author responded Author comments - Wenjun Wang
Resubmission - Version 3
15 Jan 2021 Submitted Manuscript version 3
Publishing
19 Jan 2021 Editorially accepted
25 Jan 2021 Article published 10.1186/s12879-021-05821-5

You can find further information about peer review here.

Back to article page